{
    "ticker": "ELA",
    "name": "Elekta AB",
    "description": "Elekta AB is a leading innovator in the field of medical technology, specializing in precision cancer care and neurosurgery. Established in 1972 in Sweden, Elekta has been at the forefront of developing advanced solutions that enhance the quality of care for patients suffering from cancer and brain disorders. The company offers a comprehensive range of products and services, including radiation therapy systems, software solutions for treatment planning, and imaging technologies that support clinicians in delivering personalized treatment. Elekta\u2019s flagship products, like the Versa HD and Elekta Unity, integrate cutting-edge technology with clinical expertise to ensure optimal treatment outcomes. Additionally, Elekta is committed to advancing research and education, collaborating with healthcare professionals around the world to improve patient access to effective therapies. With a strong emphasis on innovation, Elekta is continuously exploring new frontiers in medical technology, including artificial intelligence and machine learning, to further enhance treatment precision and patient care. The company's mission is to leverage technology to improve the lives of patients with cancer and neurological conditions, making a significant impact on global health.",
    "industry": [
        "Medical Technology",
        "Healthcare"
    ],
    "headquarters": "Stockholm, Sweden",
    "founded": "1972",
    "website": "https://www.elekta.com",
    "ceo": "Gustaf Salford",
    "social_media": {
        "twitter": "https://twitter.com/Elekta",
        "linkedin": "https://www.linkedin.com/company/elekta/"
    },
    "investor_relations": "https://www.elekta.com/investors/",
    "key_executives": [
        {
            "name": "Gustaf Salford",
            "position": "CEO"
        },
        {
            "name": "Lars K. Nyberg",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Radiation Therapy",
            "products": [
                "Versa HD",
                "Elekta Unity"
            ]
        },
        {
            "category": "Software Solutions",
            "products": [
                "Mosaiq",
                "Elekta Treatment Planning"
            ]
        }
    ],
    "seo": {
        "meta_title": "Elekta AB | Precision Cancer Care and Neurosurgery",
        "meta_description": "Explore Elekta AB, a leader in medical technology focused on precision cancer care and neurosurgery. Discover their innovative products, mission, and impact on healthcare.",
        "keywords": [
            "Elekta",
            "Medical Technology",
            "Cancer Care",
            "Neurosurgery",
            "Radiation Therapy",
            "Elekta Unity"
        ]
    },
    "faq": [
        {
            "question": "What does Elekta specialize in?",
            "answer": "Elekta specializes in medical technology for precision cancer care and neurosurgery."
        },
        {
            "question": "Who is the CEO of Elekta?",
            "answer": "Gustaf Salford is the CEO of Elekta AB."
        },
        {
            "question": "Where is Elekta headquartered?",
            "answer": "Elekta is headquartered in Stockholm, Sweden."
        },
        {
            "question": "What are Elekta's main products?",
            "answer": "Elekta's main products include radiation therapy systems like Versa HD and Elekta Unity, as well as software solutions."
        },
        {
            "question": "When was Elekta founded?",
            "answer": "Elekta was founded in 1972."
        }
    ],
    "competitors": [
        "VAR",
        "ISRG",
        "MRK"
    ],
    "related_stocks": [
        "PHG",
        "SYK",
        "BSX",
        "ABT"
    ]
}